title: An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database.
abstract: BACKGROUND
  There is little published guidance as to the sample size required for a pilot or feasibility trial despite the fact that a sample size justification is a key element in the design of a trial. A sample size justification should give the minimum number of participants needed in order to meet the objectives of the trial. This paper seeks to describe the target sample sizes set for pilot and feasibility randomised controlled trials, currently running within the United Kingdom.
  
  
  METHODS
  Data were gathered from the United Kingdom Clinical Research Network (UKCRN) database using the search terms 'pilot' and 'feasibility'. From this search 513 studies were assessed for eligibility of which 79 met the inclusion criteria. Where the data summary on the UKCRN Database was incomplete, data were also gathered from: the International Standardised Randomised Controlled Trial Number (ISRCTN) register; the clinicaltrials.gov website and the website of the funders. For 62 of the trials, it was necessary to contact members of the research team by email to ensure completeness.
  
  
  RESULTS
  Of the 79 trials analysed, 50 (63.3%) were labelled as pilot trials, 25 (31.6%) feasibility and 14 were described as both pilot and feasibility trials. The majority had two arms (n = 68, 86.1%) and the two most common endpoints were continuous (n = 45, 57.0%) and dichotomous (n = 31, 39.2%). Pilot trials were found to have a smaller sample size per arm (median = 30, range = 8 to 114 participants) than feasibility trials (median = 36, range = 10 to 300 participants). By type of endpoint, across feasibility and pilot trials, the median sample size per arm was 36 (range = 10 to 300 participants) for trials with a dichotomous endpoint and 30 (range = 8 to 114 participants) for trials with a continuous endpoint. Publicly funded pilot trials appear to be larger than industry funded pilot trials: median sample sizes of 33 (range = 15 to 114 participants) and 25 (range = 8 to 100 participants) respectively.
  
  
  CONCLUSIONS
  All studies should have a sample size justification. Not all studies however need to have a sample size calculation. For pilot and feasibility trials, while a sample size justification is important, a formal sample size calculation may not be appropriate. The results in this paper describe the observed sample sizes in feasibility and pilot randomised controlled trials on the UKCRN Database.
authors: Medical Statistics Group, School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, Regent Street, Sheffield S1 4DA, UK. s.a.julious@sheffield.ac.uk.
authors: Sophie A M
authors: SA
authors: Billingham
authors: Amy L
authors: AL
authors: Whitehead
authors: Steven A
authors: SA
authors: Julious
mesh_terms: D035843:Biomedical Research; D016208:Databases, Factual; D005240:Feasibility Studies; D006801:Humans; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic; D018401:Sample Size; D006113:United Kingdom
references: Clin Transl Sci. 2011 Oct;4(5):332-7
references: 22029804
references: Stat Med. 1995 Sep 15;14(17):1933-40
references: 8532986
references: BMC Med Res Methodol. 2010 Jul 16;10:67
references: 20637084
references: J Eval Clin Pract. 2004 May;10(2):307-12
references: 15189396
references: BMJ. 1995 Oct 28;311(7013):1145-8
references: 7580713
references: Stat Med. 2012 May 20;31(11-12):1031-42
references: 22052407
references: Res Nurs Health. 2008 Apr;31(2):180-91
references: 18183564
references: BMC Med Res Methodol. 2010 Jan 06;10:1
references: 20053272
references: Ann Intern Med. 2010 Aug 3;153(3):158-66
references: 20679560
references: Br Med J. 1980 Nov 15;281(6251):1336-8
references: 7437789
references: J Clin Epidemiol. 2012 Mar;65(3):301-8
references: 22169081
references: Nurs Res. 1989 Jan-Feb;38(1):60-2
references: 2911515